Christian Steinkühler

Title: Christian Steinkühler: Innovator in HCV Research

Introduction

Christian Steinkühler is a notable inventor based in Rome, Italy. He has made significant contributions to the field of molecular biology, particularly in the study of hepatitis C virus (HCV) proteases. His innovative work has led to advancements in the development of therapeutic agents against HCV.

Latest Patents

Steinkühler holds a patent for a methodology to produce, purify, and assay polypeptides with the proteolytic activity of the HCV NS3 protease. This process allows for the expression and isolation of polypeptides in a pure, catalytically active form. The invention is crucial for discovering NS3 protease inhibitors and determining the three-dimensional structure of the NS3 protease. Additionally, it defines the necessary chemical and physical conditions for the proteolytic activity of these polypeptides. The patent also includes new compositions of matter, such as expression vectors containing nucleotide sequences capable of expressing the polypeptides in cultured cells. Furthermore, it defines new compounds suitable for measuring proteolytic activity, which are useful in developing therapeutic agents against HCV.

Career Highlights

Christian Steinkühler is associated with the Istituto di Ricerche di Biologia Molecolare S.p.a., where he continues to advance research in molecular biology. His work has been instrumental in understanding the mechanisms of HCV and developing potential treatments.

Collaborations

Steinkühler has collaborated with notable colleagues, including Antonello Pessi and Elisabetta Bianchi, who have contributed to his research endeavors.

Conclusion

Christian Steinkühler's innovative methodologies and research in HCV proteases have the potential to significantly impact the development of therapeutic agents. His contributions to molecular biology exemplify the importance of innovation in addressing global health challenges.